vimarsana.com

Latest Breaking News On - Agonist use - Page 1 : vimarsana.com

GLP1 receptor agonists do not up risk for complications after emergency surgery

GLP1 receptor agonists do not up risk for complications after emergency surgery
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Study reveals surge in use of weight loss-linked drugs in California health system

Study reveals surge in use of weight loss-linked drugs in California health system
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Skyrocketing demand for weight-loss drugs prompts calls for informed prescribing

The study reveals a significant increase in the usage of GLP-1 receptor agonists, particularly Ozempic and Trulicity, for weight management and Type 2 diabetes in the U.S. from 2014 to 2022. Amidst rapid growth and shortages, the paper calls for evidence-based decision-making to ensure stable medication supply and effective treatment.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.